New York, Feb 13, 2026, 13:59 (EST) — Regular session
- Moolec Science SA shares surged 85.6% to $9.47, trading roughly 44.7 million shares.
- Shares moved within a band from $8.12 up to $12.23 during the session
- Commercial-scale results are in from the company’s GLASO1 engineered safflower platform.
Moolec Science SA surged in afternoon trading Friday, tacking on 85.6% to $9.47 at 1:39 p.m. Eastern. The rally triggered several volatility halts as shares swung between $8.12 and $12.23, with volume hitting roughly 44.7 million shares, according to MarketBeat.
Moolec describes itself as a food ingredient company grounded in science, splicing animal protein genes into plants—a play in the wider world of so-called “molecular farming.” Investors eye whether these engineered traits can actually make it from experimental plots into large-scale food processing without breaking down. Moolec Science
This stock can swing sharply on just one operations update. In thinly traded names, the smallest catalyst—a press release, a sudden flood of orders—can send the tape moving fast.
On Friday, trading stopped five separate times for “volatility pause” halts, Cboe’s halt list showed—including one break at 11:58 a.m. Eastern. These halts kicked in under the Limit Up-Limit Down system, which steps in automatically to curb rapid price swings. Cboe Global Markets
Moolec reported that its 2025 U.S. GLASO1 safflower crop went through regular U.S. crushing channels, yielding gamma-linolenic acid levels around 45%. The company planted 1,100 acres this cycle, pulling in an average of about 2,200 pounds per acre—up from last year’s 1,400. “Inflection point,” according to chief executive Alejandro Antalich. Now, he said, the focus is on translating the operational win into “sustainable, recurring revenue.” Nasdaq
This follows a reverse split not long ago. The company’s January filing put the 15-for-1 consolidation in effect on Jan. 5, shrinking its outstanding shares to 726,118 from roughly 10.9 million.
Still, the rally leaves the main issue unresolved: can Moolec move specialty oil in volume, keep prices firm, and avoid needing more cash. Trading saw more than one halt and wide swings; if volume dries up or momentum fades, all those gains could unwind just as quickly.
Eyes are on Moolec’s next moves as the company counts down its Nasdaq compliance clock. Back in late January, Nasdaq disclosed that a Hearings Panel would let Moolec stay listed for now, but only if it meets a set of conditions: a status update must hit by the end of February, updated pro forma numbers are due by the end of March, and the panel is keeping oversight until May 13.
